In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. 

Here are the key articles discussed:

1.      Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/

2.     Mayo 2004 staging:  https://pubmed.ncbi.nlm.nih.gov/15365071/

3.     Mayo 2012 staging: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675680/

4.     Renal staging: https://pubmed.ncbi.nlm.nih.gov/25115890/

5.     Hematologic and cardiac response criteria in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/23091105/

6.     ANDROMEDA Trial: Dara-VCD vs VCD in newly diagnosed AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34192431/

7.      How I Treat AL Amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34517412/

8.     Venetoclax in AL amyloidosis (largest retrospective study till date): 

https://pubmed.ncbi.nlm.nih.gov/33431806/